| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, Florida 33136; and 2 Department of Anesthesiology, Mayo Foundation, Rochester, Minnesota 55905
Cardiac muscle contraction depends on the tightly regulated interactions of thin and thick filament proteins of the contractile apparatus. Mutations of thin filament proteins (actin, tropomyosin, and troponin), causing familial hypertrophic cardiomyopathy (FHC), occur predominantly in evolutionarily conserved regions and induce various functional defects that impair the normal contractile mechanism. Dysfunctional properties observed with the FHC mutants include altered Ca2+ sensitivity, changes in ATPase activity, changes in the force and velocity of contraction, and destabilization of the contractile complex. One apparent tendency observed in these thin filament mutations is an increase in the Ca2+ sensitivity of force development. This trend in Ca2+ sensitivity is probably induced by altering the cross-bridge kinetics and the Ca2+ affinity of troponin C. These in vitro defects lead to a wide variety of in vivo cardiac abnormalities and phenotypes, some more severe than others and some resulting in sudden cardiac death.
familial hypertrophic cardiomyopathy; troponin; tropomyosin; actin; myocardium
This article has been cited by other articles:
|
|
 |
|
  S. J. van Dijk, D. Dooijes, C. dos Remedios, M. Michels, J. M.J. Lamers, S. Winegrad, S. Schlossarek, L. Carrier, F. J. ten Cate, G. J.M. Stienen, et al. Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy: Haploinsufficiency, Deranged Phosphorylation, and Cardiomyocyte Dysfunction Circulation, March 24, 2009; 119(11): 1473 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Sakata, H Ino, N Fujino, M Nagata, K Uchiyama, K Hayashi, T Konno, M Inoue, H Kato, Y Sakamoto, et al. Exercise-induced systolic dysfunction in patients with non-obstructive hypertrophic cardiomyopathy and mutations in the cardiac troponin genes Heart, October 1, 2008; 94(10): 1282 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Pinto, M. S. Parvatiyar, M. A. Jones, J. Liang, and J. D. Potter A Troponin T Mutation That Causes Infantile Restrictive Cardiomyopathy Increases Ca2+ Sensitivity of Force Development and Impairs the Inhibitory Properties of Troponin J. Biol. Chem., January 25, 2008; 283(4): 2156 - 2166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Robinson, P. J. Griffiths, H. Watkins, and C. S. Redwood Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and {alpha}-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments Circ. Res., December 7, 2007; 101(12): 1266 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, G. M. Arteaga, R. John Solaro, S. B. Liggett, and D. F. Wieczorek Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H949 - H958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Robinson, S. Lipscomb, L. C. Preston, E. Altin, H. Watkins, C. C. Ashley, and C. S. Redwood Mutations in fast skeletal troponin I, troponin T, and {beta}-tropomyosin that cause distal arthrogryposis all increase contractile function FASEB J, March 1, 2007; 21(3): 896 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chandra, M. L. Tschirgi, and J. C. Tardiff Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2112 - H2119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sanbe, J. James, V. Tuzcu, S. Nas, L. Martin, J. Gulick, H. Osinska, S. Sakthivel, R. Klevitsky, K. S. Ginsburg, et al. Transgenic Rabbit Model for Human Troponin I-Based Hypertrophic Cardiomyopathy Circulation, May 10, 2005; 111(18): 2330 - 2338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Venkatraman, A. V. Gomes, W. G. L. Kerrick, and J. D. Potter Characterization of Troponin T Dilated Cardiomyopathy Mutations in the Fetal Troponin Isoform J. Biol. Chem., May 6, 2005; 280(18): 17584 - 17592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Moss, M. Razumova, and D. P. Fitzsimons Myosin Crossbridge Activation of Cardiac Thin Filaments: Implications for Myocardial Function in Health and Disease Circ. Res., May 28, 2004; 94(10): 1290 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Harada and J. D. Potter Familial Hypertrophic Cardiomyopathy Mutations from Different Functional Regions of Troponin T Result in Different Effects on the pH and Ca2+ Sensitivity of Cardiac Muscle Contraction J. Biol. Chem., April 9, 2004; 279(15): 14488 - 14495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Venkatraman, K. Harada, A. V. Gomes, W. G. L. Kerrick, and J. D. Potter Different Functional Properties of Troponin T Mutants That Cause Dilated Cardiomyopathy J. Biol. Chem., October 24, 2003; 278(43): 41670 - 41676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Heller, M. Nili, E. Homsher, and L. S. Tobacman Cardiomyopathic Tropomyosin Mutations That Increase Thin Filament Ca2+ Sensitivity and Tropomyosin N-domain Flexibility J. Biol. Chem., October 24, 2003; 278(43): 41742 - 41748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Van Driest, E. G. Ellsworth, S. R. Ommen, A. J. Tajik, B. J. Gersh, and M. J. Ackerman Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy * Note Added in Proof Circulation, July 29, 2003; 108(4): 445 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Robinson, M. Mirza, A. Knott, H. Abdulrazzak, R. Willott, S. Marston, H. Watkins, and C. Redwood Alterations in Thin Filament Regulation Induced by a Human Cardiac Troponin T Mutant That Causes Dilated Cardiomyopathy Are Distinct from Those Induced by Troponin T Mutants That Cause Hypertrophic Cardiomyopathy J. Biol. Chem., October 18, 2002; 277(43): 40710 - 40716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Westfall, A. R. Borton, F. P. Albayya, and J. M. Metzger Myofilament Calcium Sensitivity and Cardiac Disease: Insights From Troponin I Isoforms and Mutants Circ. Res., September 20, 2002; 91(6): 525 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, M. X. Li, and B. D. Sykes Structure of the Regulatory N-domain of Human Cardiac Troponin C in Complex with Human Cardiac Troponin I147-163 and Bepridil J. Biol. Chem., August 16, 2002; 277(34): 31124 - 31133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lang, A. V. Gomes, J. Zhao, P. R. Housmans, T. Miller, and J. D. Potter Functional Analysis of a Troponin I (R145G) Mutation Associated with Familial Hypertrophic Cardiomyopathy J. Biol. Chem., March 29, 2002; 277(14): 11670 - 11678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Morimoto, Q.-W. Lu, K. Harada, F. Takahashi-Yanaga, R. Minakami, M. Ohta, T. Sasaguri, and I. Ohtsuki Ca2+-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy PNAS, January 1, 2002; (2002) 22628899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, G. Z. Czernuszewicz, O. Gonzalez, T. Tapscott, A. Karibe, J.-B. Durand, R. Brugada, R. Hill, J. M. Gregoritch, J. L. Anderson, et al. Novel Cardiac Troponin T Mutation as a Cause of Familial Dilated Cardiomyopathy Circulation, October 30, 2001; 104(18): 2188 - 2193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Morimoto, Q.-W. Lu, K. Harada, F. Takahashi-Yanaga, R. Minakami, M. Ohta, T. Sasaguri, and I. Ohtsuki Ca2+-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy PNAS, January 22, 2002; 99(2): 913 - 918. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
